Parliamentary QA
MEDISAVE WITHDRAWAL LIMITS FOR IN-VITRO FERTILITY TREATMENTS
19 September 2023
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
NOTICE PAPER NO. 2186
NOTICE OF QUESTION FOR WRITTEN ANSWER
FOR SITTING OF PARLIAMENT ON 19 SEPTEMBER 2023
Name and Constituency of Member of Parliament
Mr Louis Ng Kok Kwang
MP for Nee Soon GRC
Question No. 4974
To ask the Minister for Health (a) whether the Ministry has reviewed the Medisave withdrawal limits for in-vitro fertility (IVF) treatments recently; and (b) whether it will consider increasing the Medisave withdrawal limit for IVF treatments.
Answer
1 Our financing schemes remain adequate for subsidised Assisted Conception Procedures (ACP).
2 To support affordability of ACPs, Government co-funding of up to 75% is available at public Assisted Reproduction centres, with MediSave withdrawals limits of up to $6,000 per cycle. A lifetime withdrawal limit of $15,000 per patient is also in place to avoid premature depletion of MediSave balances towards ACPs.
3 After co-funding and MediSave usage for the first ACP cycle, eight in 10 eligible Singapore Citizen (SC) couples would incur no out-of-pocket expense, while nine in 10 eligible SC couples would pay no more than $500. The Ministry of Health will continue to monitor the affordability of ACPs and review our financing schemes if necessary.